LBD
TXG icon

Landsberg Bennett & Dubbaneh’s 10x Genomics TXG Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$278K Sell
1,932
-116
-6% -$19.9K 0.04% 244
2021
Q2 		$412K Buy
2,048
+254
+14% +$46K 0.05% 182
2021
Q1 		$333K Buy
+1,794
New +$310K 0.05% 198

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's TXG Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its 10x Genomics (TXG) stake by 5.7% in Q3 2021, selling an estimated $19.9K and leaving 1,932 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #244.

Landsberg Bennett & Dubbaneh first reported a position in TXG in Q1 2021 and has held it in 3 quarters since. The position peaked at $412K in Q2 2021. 330 funds tracked by Wall St. Rank hold TXG as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 1,932 shares of 10x Genomics worth $278K as of Q3 2021.
  • Landsberg Bennett & Dubbaneh sold 116 10x Genomics shares in Q3 2021, an estimated $19.9K.
  • 10x Genomics made up 0.04% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #244 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in 10x Genomics in Q1 2021 and has held it in 3 quarters since.
  • Landsberg Bennett & Dubbaneh's 10x Genomics position peaked at $412K in Q2 2021.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.